HYDROXYZINE HCL 25 MG TABLET
For 30 tablets
Pharmacies pay
$0.98 filed
30 × $0.03255 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$6.37 filed
30 × $0.21227 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
6.5× estimated
Medicare paid 6.5× what pharmacies pay.
Part D averages every strength and form sold under “Hydroxyzine HCl*” / “Hydroxyzine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.13 estimated
$0.98 + $0.15 (15%) + $5.00 fee per fill = $6.13
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
HYDROXYZINE HCL 25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydroxyzine hydrochloride.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and KVK-Tech, Inc.
FDA’s Established Pharmacologic Class for it is Antihistamine.
The NADAC file of 2026-10-14 prices it under 25 NDCs (National Drug Codes); the FDA directory lists 24 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.98 for 30 tablets (30 × $0.03255 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Aurobindo Pharma Limited | 3 | $0.03255 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 3 | $0.03255 per EA filed |
| KVK-Tech, Inc. | 3 | $0.03255 per EA filed |
| Northstar RxLLC | 3 | $0.03255 per EA filed |
| Rising Pharma Holdings, Inc. | 3 | $0.03255 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 3 | $0.03255 per EA filed |
| Chartwell RX, LLC | 2 | $0.03255 per EA filed |
| Major Pharmaceuticals | 2 | $0.03255 per EA filed |
| American Health Packaging | 1 | $0.03255 per EA filed |
| PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 1 | $0.03255 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.03255 per EA filed |
All 25 NDCs, with labeler and price
- 00093-5061-01 · Teva Pharmaceuticals USA, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 00093-5061-05 · Teva Pharmaceuticals USA, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 00093-5061-10 · Teva Pharmaceuticals USA, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 00904-7378-40 · Major Pharmaceuticals · $0.03255 per EA · eff. 2026-09-23 filed
- 00904-7378-80 · Major Pharmaceuticals · $0.03255 per EA · eff. 2026-09-23 filed
- 10702-0011-01 · KVK-Tech, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 10702-0011-10 · KVK-Tech, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 10702-0011-50 · KVK-Tech, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 16571-0114-01 · Rising Pharma Holdings, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 16571-0114-10 · Rising Pharma Holdings, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 16571-0114-50 · Rising Pharma Holdings, Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 16714-0082-10 · Northstar RxLLC · $0.03255 per EA · eff. 2026-09-23 filed
- 16714-0082-11 · Northstar RxLLC · $0.03255 per EA · eff. 2026-09-23 filed
- 16714-0082-12 · Northstar RxLLC · $0.03255 per EA · eff. 2026-09-23 filed
- 23155-0501-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 23155-0501-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 23155-0501-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03255 per EA · eff. 2026-09-23 filed
- 24658-0782-10 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS · $0.03255 per EA · eff. 2026-09-23 filed
- 59651-0500-01 · Aurobindo Pharma Limited · $0.03255 per EA · eff. 2026-09-23 filed
- 59651-0500-05 · Aurobindo Pharma Limited · $0.03255 per EA · eff. 2026-09-23 filed
- 59651-0500-99 · Aurobindo Pharma Limited · $0.03255 per EA · eff. 2026-09-23 filed
- 60687-0675-01 · American Health Packaging · $0.03255 per EA · eff. 2026-09-23 filed
- 60687-0675-11 · not listed as a package in the FDA directory · $0.03255 per EA · eff. 2026-09-23 filed
- 62135-0574-05 · Chartwell RX, LLC · $0.03255 per EA · eff. 2026-09-23 filed
- 62135-0574-12 · Chartwell RX, LLC · $0.03255 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share the FDA nonproprietary name hydroxyzine hydrochloride with HYDROXYZINE HCL 25 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| HYDROXYZINE 10 MG/5 ML SOLN | $0.11321 per ML filed | We don’t know yet |
| HYDROXYZINE 10 MG/5 ML SYRUP | $0.11321 per ML filed | We don’t know yet |
| HYDROXYZINE HCL 10 MG TABLET | $0.02867 per EA filed | $0.21227 per EA filed |
| HYDROXYZINE HCL 25 MG TABLET this page | $0.03255 per EA filed | $0.21227 per EA filed |
| HYDROXYZINE HCL 50 MG TABLET | $0.05575 per EA filed | $0.21227 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 25 NDCs’ NADAC prices is $0.03255 per EA filed.
Of the 21 other products in FDA’s Antihistamine class priced per EA, 20 have a higher middle NADAC price and 1 a lower one. The one in the middle is GS SLEEP AID ULTRA 25 MG TAB, at $0.11579 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $6.37 for 30 tablets, at an average of $0.21227 per EA in 2024 (2024-01-01 to 2024-12-31) for “Hydroxyzine HCl*” and “Hydroxyzine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 4,702,557 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for HYDROXYZINE HCL 25 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Hydroxyzine HCl* / Hydroxyzine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 70 NADAC NDCs the name join matched to it have an FDA route including ORAL. 3 of the 63 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 63 of 70 NADAC NDCs joined to this name are priced per EA (7 per ML): CMS's average mixes those units.
Related pages
Its pharmacologic class
Related in the same class
- BENZTROPINE MES 0.5 MG TAB
- HYDROXYZINE PAM 100 MG CAP
- ALL-NITE COLD-FLU RELIEF LIQ
- BONJESTA ER 20-20 MG TABLET
- FT SLEEP AID 25 MG TABLET